https://twitter.com/Calliditas1/status/1721875203347611871It was an honor to connect with the rare #KidneyDisease community at @ASNKidney’s #KidneyWk & showcase our pioneering work in IgA nephropathy. Learn about the additional analyses we presented from our Ph3 NefIgArd trial for the treatment of #IgAN, & more: https://bit.ly/3QrfcW8 https://bit.ly/3Qrff4g
— Calliditas Therapeutics (@Calliditas1) Nov 7, 2023
Tuesday, November 7, 2023
@Calliditas1
http://twitter.com/Calliditas1
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment